Cited 3 time in
Clinical outcomes of sedation during emergency endoscopic band ligation for variceal bleeding: Multicenter cohort study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Chan Hyuk | - |
| dc.contributor.author | Park, Se Woo | - |
| dc.contributor.author | Jung, Jang Han | - |
| dc.contributor.author | Kim, Gyeong Guk | - |
| dc.contributor.author | Choi, Se Young | - |
| dc.contributor.author | Kim, Eun Sun | - |
| dc.contributor.author | In, Dong Hyun | - |
| dc.contributor.author | Kim, Hong Deok | - |
| dc.date.accessioned | 2021-08-02T08:52:55Z | - |
| dc.date.available | 2021-08-02T08:52:55Z | - |
| dc.date.created | 2021-05-11 | - |
| dc.date.issued | 2020-09 | - |
| dc.identifier.issn | 0915-5635 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/8984 | - |
| dc.description.abstract | Background and Aims Few studies have directly compared the efficacy of sedated- and un-sedated endoscopic variceal ligation (EVL) for acute variceal bleeding. We aimed to determine whether sedation during EVL in patients with variceal bleeding is safe and effective. Methods We analyzed data from patients who underwent EVL for acute variceal bleeding according to sedation in six hospitals of Hallym University Medical Center. The primary endpoint was treatment failure, defined as a failure to control bleeding, death during EVL, or rebleeding within 5 days. Secondary endpoints included the procedure time, adverse events, and 30-day mortality. Results Of 1,300 patients who were included, only 430 (33.1%) received sedation during EVL. Propofol alone was used for sedation in 85% of sedated-EVLs. The mean procedure time in the sedation group was shorter than that of the non-sedation group (12.4± 9.5 min versus 13.8 ±9.4 min,P = 0.010). The proportion of treatment failure did not differ between the groups (7.4% versus 9.1%,P = 0.374). In the multivariable analysis, an AIMS65 score >= 2 and blood transfusion within 72 hours were associated with treatment failure of EVL; however, the use of sedation was not (odds ratio [95% confidence interval (CI)] = 0.96 [0.60-1.51]). Adverse events during EVL and hepatic encephalopathy did not differ between the two groups. Sedation also did not affect the 30-day mortality (hazard ratio [95% CI] = 0.99 [0.66-1.47]). Conclusion Sedation reduced the procedure time of EVL. Sedation is safe to use during EVL for variceal bleeding in patients with cirrhosis. | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | WILEY | - |
| dc.title | Clinical outcomes of sedation during emergency endoscopic band ligation for variceal bleeding: Multicenter cohort study | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Park, Chan Hyuk | - |
| dc.identifier.doi | 10.1111/den.13610 | - |
| dc.identifier.scopusid | 2-s2.0-85081740726 | - |
| dc.identifier.wosid | 000563149000001 | - |
| dc.identifier.bibliographicCitation | DIGESTIVE ENDOSCOPY, v.32, no.6, pp.894 - 903 | - |
| dc.relation.isPartOf | DIGESTIVE ENDOSCOPY | - |
| dc.citation.title | DIGESTIVE ENDOSCOPY | - |
| dc.citation.volume | 32 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 894 | - |
| dc.citation.endPage | 903 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Article | - |
| dc.description.journalClass | 1 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
| dc.relation.journalResearchArea | Surgery | - |
| dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
| dc.relation.journalWebOfScienceCategory | Surgery | - |
| dc.subject.keywordPlus | UPPER GASTROINTESTINAL ENDOSCOPY | - |
| dc.subject.keywordPlus | IN-HOSPITAL MORTALITY | - |
| dc.subject.keywordPlus | CIRRHOTIC-PATIENTS | - |
| dc.subject.keywordPlus | PROPOFOL SEDATION | - |
| dc.subject.keywordPlus | SUBMUCOSAL DISSECTION | - |
| dc.subject.keywordPlus | CONTROLLED-TRIAL | - |
| dc.subject.keywordPlus | MIDAZOLAM | - |
| dc.subject.keywordPlus | RISK | - |
| dc.subject.keywordPlus | HEMORRHAGE | - |
| dc.subject.keywordPlus | SAFETY | - |
| dc.subject.keywordAuthor | bleeding | - |
| dc.subject.keywordAuthor | endoscopy | - |
| dc.subject.keywordAuthor | hemostasis | - |
| dc.subject.keywordAuthor | sedation | - |
| dc.subject.keywordAuthor | varix | - |
| dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/den.13610 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
